Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

RIGL holding history

Rigel Pharmaceuticals Inc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RIGL overviewAll 13F holders of RIGLFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of RIGL by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−131,199−100.0%Sold outHolders
Q1 2026131,199$3.55M<0.1%−54,220−29.2%ReducedHolders
Q4 2025185,419$7.94M<0.1%+98,955+114.4%AddedHolders
Q3 202586,464$2.45M<0.1%+86,464NewHolders
Q1 20250$00.0%−28,411−100.0%Sold outHolders
Q4 202428,411$477.9K<0.1%+28,411NewHolders
Q3 20240$00.0%−16,208−100.0%Sold outHolders
Q2 202416,208$133.2K<0.1%−27,166−62.6%ReducedConverted for a 1-for-10 splitHolders
Q1 2024433,736$641.9K<0.1%+408,771+1,637.4%AddedHolders
Q4 202324,965$36.2K<0.1%+22,799+1,052.6%AddedHolders
Q3 20232,166$2.34K<0.1%+142+7.0%AddedHolders
Q2 20232,024$2.61K<0.1%−52,318−96.3%ReducedHolders
Q1 202354,342$71.7K<0.1%−1,713,657−96.9%ReducedHolders
Q4 20221,767,999$2.65M<0.1%−2,815,349−61.4%ReducedHolders
Q3 20224,583,348$5.41M<0.1%+685,864+17.6%AddedHolders
Q2 20223,897,484$4.40M<0.1%−70,527−1.8%ReducedHolders
Q1 20223,968,011$11.9M<0.1%+2,552,290+180.3%AddedHolders
Q4 20211,415,721$3.75M<0.1%+1,276,206+914.7%AddedHolders
Q3 2021139,515$506.0K<0.1%+65,015+87.3%AddedHolders
Q2 202174,500$323.0K<0.1%−3,221,586−97.7%ReducedHolders
Q1 20213,296,086$11.3M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.